Clinical Trial Update: Atrial Fibrillation Clopidogrel Trial With Irbesartan for Prevention of Vascular Events (ACTIVE A) [Phase 3]

View source ↗

Summary

A Phase 3 trial (ACTIVE A) evaluated clopidogrel with irbesartan to prevent vascular events in patients with atrial fibrillation; the study completed and result…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Atrial Fibrillation

Drugs mentioned

• Clopidogrel (Plavix) (clopidogrel)
• Irbesartan (Avapro) (irbesartan)

Snippet

Sponsor: Sanofi | Conditions: Atrial Fibrillation, Vascular Risk | Phase 3 | Status: COMPLETED | Results posted: 2010-03-26